AJ Vaccines A/S: Financial statements 2023
CVR: 37911143
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 468,886,000 and a net result of DKK -242,974,000 compared with DKK -268,090,000 the year before. That is an increase of 11.4% compared with the year before. The profit margin was -51.8%. Equity in the 2023 report amounted to DKK 1,020,362,000. The solvency ratio was 64.3%. The company had 577 employees in the financial year.
- Revenue
- DKK 468,886,000
- Gross Profit
- DKK -30,723,000
- Profit/Loss
- DKK -242,974,000
- Equity
- DKK 1,020,362,000
- Total Assets
- DKK 1,587,337,000
- Employees
- 577
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 468.9M | -30.7M | -243M | 1B | 577 |
| 2022 | 421M | -66M | -268.1M | 994.7M | 556 |
| 2021 | 351.9M | -304M | -486.4M | 815.9M | 558 |
| 2020 | 351.6M | -313.9M | -450.2M | 1.1B | 702 |
| 2019 | 323.5M | -224.5M | -288.6M | 1.2B | 719 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of August 28, 2023, Abdulaziz Abdulhamid Abdulrhman Albassam has joined the board of directors of AJ Vaccines A/S.
As of August 28, 2023, Abdulaziz Hamad Aljomaih has left the board of directors of AJ Vaccines A/S.
AJ Vaccines A/S has published its annual report for 2022. Revenue came to DKK 420,982,000, and the net result was DKK -268,090,000.
About AJ Vaccines A/S
AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.
